VC23

VC23 focuses on early-stage companies, specifically seed and startup rounds. The firm writes first institutional checks typically when founders have a working product and early commercial traction rather than at the pre-revenue concept stage. This positions VC23 as a lead or co-lead investor in rounds where technical risk has been partially retired but go-to-market risk remains.

VC23 concentrates on enterprise software, applied AI and machine learning, fintech infrastructure, and digital health. The firm looks for B2B companies with technical moats. It has not publicly disclosed interest in consumer internet, hardware, or capital-intensive climate-tech verticals.

Public records indicate VC23 invests primarily in US-based companies, with a likely concentration in the Northeast corridor given its Connecticut headquarters. The firm has not disclosed international portfolio companies or non-US office locations. Its sourcing network appears centered on East Coast academic, insurance-tech, and industrial-tech ecosystems.

VC23's Connecticut location gives it differentiated access to deal flow from Northeast university spinouts, regional fintech and insurtech founders, and precision-manufacturing startups — networks that large coastal venture firms often underweight. The firm likely supplements this with angel syndicate relationships and Connecticut Innovation Ecosystem partnerships, though no formal sourcing programs are publicly documented.

VC23's stated stage coverage spans early seed through startup, suggesting a willingness to follow on selectively when portfolio companies reach commercial inflection points. The firm has not disclosed a dedicated reserves policy or opportunity fund structure for follow-on capital, so allocation decisions are likely made on a deal-by-deal basis.